MetaADEDB 2.0 @ LMMD
imidapril
(KLZWOWYOHUKJIG-BPUTZDHNSA-N)
Structure
SMILES
CCOC(=O)[C@@H](N[C@H](C(=O)N1C(=O)N(C[C@H]1C(=O)O)C)C)CCc1ccccc1
Type(s)
Investigational
ATC code(s)
C09AA16
Molecular Formula:
C20H27N3O6
Molecular Weight:
405.445
Log P:
1.1429
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
2
TPSA:
116.25
CAS Number(s):
89371-37-9
Synonym(s)
1.
imidapril
2.
1-methyl-3-(2-(N-(1-ethoxycarbonyl-3-phenylpropyl)amino)propionyl)-2-oxoimidazolidine-4-carboxylic acid
3.
4-imidazolidinecarboxylic acid, 3-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1-methyl-2-oxo-, monohydrochloride, (4S-(3(R*(R*)),4R*))-
4.
TA 6366
5.
TA-6366
6.
Tanatril
7.
imidapril HCl
8.
imidapril hydrochloride
External Link(s)
MeSHC065166
PubChem Compound40466903
5464343
BindingDB50020400
ChEBI135654
CHEMBLCHEMBL317094
DrugBankDB11783
DrugCentral1424
IUPHAR/BPS Guide to PHARMACOLOGY6377
KEGGdr:D08068
ZINC3784427
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acute bronchitisOFFSIDES
2Albuminuria10862828CTD
3Alcohol interactionOFFSIDES
4Altered state of consciousnessOFFSIDES
5Angioedema18946239CTD
6AnorexiaOFFSIDES
7Anticholinergic SyndromeOFFSIDES
8ApathyOFFSIDES
9Arteriosclerosis ObliteransOFFSIDES
10Aspiration PneumoniaOFFSIDES
11Atrial FlutterOFFSIDES
12Atrial tachycardiaOFFSIDES
13Blood creatine increasedOFFSIDES
14Blood creatine phosphokinase MB increasedOFFSIDES
15Blood creatine phosphokinase increasedOFFSIDES
16Blood creatinine increasedOFFSIDES
17Blood lactate dehydrogenase increasedOFFSIDES
18Blood sodiumOFFSIDES
19Blood triglycerides increasedOFFSIDES
20Blood urea increasedOFFSIDES
21Blood uric acidOFFSIDES
22BradycardiaOFFSIDES
23Cerebellar infarctionOFFSIDES
24CholangiolitisOFFSIDES
25CholecystitisOFFSIDES
26Colon adenomaOFFSIDES
27Completed SuicideOFFSIDES
28Creatinine renal clearance decreasedOFFSIDES
29DiverticulosisOFFSIDES
30Duodenal UlcerOFFSIDES
31DysgeusiaOFFSIDES
32DysphoniaOFFSIDES
33DysuriaOFFSIDES
34EczemaOFFSIDES
35Endotoxic shockOFFSIDES
36Enterovesical FistulaOFFSIDES
37EpilepsyOFFSIDES
38ErythemaOFFSIDES
39Gamma-Glutamyltransferase IncreasedOFFSIDES
40Global AmnesiaOFFSIDES
41GlobulinuriaOFFSIDES
42Head titubationOFFSIDES
43Heart failure15576437
15681692
CTD
44HemiplegiaOFFSIDES
45Hepatitis COFFSIDES
46Hyperemia11973410CTD
47HypokinesiaOFFSIDES
48IncontinenceOFFSIDES
49Intestinal PerforationOFFSIDES
50Limb discomfortOFFSIDES
51Mallory-Weiss SyndromeOFFSIDES
52MononeuritisOFFSIDES
53MonoplegiaOFFSIDES
54Multiple drug overdose intentionalOFFSIDES
55Muscular DystrophyOFFSIDES
56Myocardial Infarction8028230CTD
57Myoglobin blood increasedOFFSIDES
58Myoglobin urine presentOFFSIDES
59Nephrotic SyndromeOFFSIDES
60Neutrophil count decreasedOFFSIDES
61NocturiaOFFSIDES
62NystagmusOFFSIDES
63OsteomyelitisOFFSIDES
64Pneumocystis jiroveci pneumoniaOFFSIDES
65Post procedural infectionOFFSIDES
66Pulmonary congestionOFFSIDES
67PyelonephritisOFFSIDES
68QuadriplegiaOFFSIDES
69Sinus bradycardiaOFFSIDES
70Stevens-Johnson SyndromeOFFSIDES
71Subcutaneous AbscessOFFSIDES
72Therapy non-responderOFFSIDES
73TinnitusOFFSIDES
74Tolosa-Hunt SyndromeOFFSIDES
75UrethritisOFFSIDES
76Vibration test abnormalOFFSIDES
77Visual acuity reduced transientlyOFFSIDES
78Visual disturbanceOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.